About Previvo Genetics
Previvo Genetics is a Healthcare company based in San Jose (United States) founded in 2012 by John Buster. Preimplantation genetic diagnostics and embryo screening devices are developed. Previvo Genetics has raised $6.83 million across 2 funding rounds. Its focus areas include Life Sciences, Clinical Genomics, Sequencing Based and Genetic Testing. Its legal entity is Previvo Genetics, Inc. Its competitors include Gynesonics, Minerva Surgical and Channel Medsystems; 3 of its 3 listed competitors have raised funding.
Company details
Founded in 2012 in San Jose, United States, Previvo Genetics operates in the biotechnology sector focused on reproductive health. The companys Previvo Uterine Lavage System is utilized to extract post-IVF blastocysts from the uterus noninvasively. These embryos are then screened for genetic abnormalities, with viable ones selected for re-implantation to support fertility treatments.
- Headquarters San Jose, United States
- Founders John Buster
- SectorsHealthcare
- Phone•••• ••••
- Website previvo.com
- Social LinkedIn X Instagram
- Legal Name Previvo Genetics, Inc.
- Total Equity Funding$6.83M (USD)
in 2 rounds
- Latest Funding Round$3.41M (USD), Series A
Sep 2016
Funding Insights of Previvo Genetics
Previvo Genetics has successfully raised a total of $6.83M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $3.41 million completed in September 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $6.83M
- Total Rounds 2
- Last Round Series A — $3.41M
- First Round $3.41M
(Sep 2016)
All 2 funding rounds of Previvo Genetics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2016 | $3.41M | Series A | – | – | – |
| Sep 2016 | $3.41M | Series A | – | – | – |
People of Previvo Genetics
1 people are tracked at Previvo Genetics (1 in leadership).
| Name | Role | Group |
|---|---|---|
John Buster | Founder | Leadership |
Complete people profiles for Previvo Genetics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Previvo Genetics
3 dated milestones of Previvo Genetics across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Previvo Genetics is founded.
- Funding First funding round of $3.4M.
- Funding Latest funding round, Series A, of $3.4M.
Competitors of Previvo Genetics
Previvo Genetics has 3 listed competitors in our database, 3 of them funded. They include Gynesonics, Minerva Surgical and Channel Medsystems.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| gynesonics.com | 2005 | Redwood, United States | $282.54M | 92 | A minimally invasive ablation system for uterine fibroids is developed. | |
| minervasurgical.com | 2008 | Redwood, United States | $135.1M | 155 | Minerva Surgical is focused on uterine health solutions. | |
| channelmedsystems.com | 2009 | San Francisco, United States | $47.67M | 37 | Cryothermic technology for endometrial ablation to control heavy bleeding |
Detailed competitors of Previvo Genetics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Previvo Genetics (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Previvo Genetics
Previvo Genetics was founded in 2012 and raised its 1st funding round 4 years after it was founded.
Previvo Genetics is headquartered in San Jose, United States. It is registered at San Jose, California, United States.
Previvo Genetics is a funded company, having raised a total of $6.83M across 2 funding rounds to date. The company's 1st funding round was a Series A of $3.41M, raised on Sep 2016.
Founded in 2012 in San Jose, United States, Previvo Genetics operates in the biotechnology sector focused on reproductive health. The companys Previvo Uterine Lavage System is utilized to extract post-IVF blastocysts from the uterus noninvasively. These embryos are then screened for genetic abnormalities, with viable ones selected for re-implantation to support fertility treatments.
Previvo Genetics's top competitors include Gynesonics, Channel Medsystems and Minerva Surgical.
Previvo Genetics operates through Previvo Genetics, Inc..